Skip to main content

Table 1 Main clinical characteristics and parameters in 447 patients with ESCC

From: Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma

Characteristics Median (25th–75th percentile) or no. (%)
Gender (n)
 Male 346 (77.4)
 Female 101 (22.6)
Age
  < 59 years 233 (52.1)
  ≥ 59 years 214 (47.9)
Alcohol (n)
 No 261 (58.4)
 Yes 186 (41.6)
Tumor location
 Upper 41 (9.2)
 Middle 278 (62.2)
 Lower 128 (28.6)
Stage (n)
 I and II 235 (52.6)
 III and IV 212 (47.4)
Treatment (n)
 Surgery only 238 (53.2)
 Surgery and chemotherapy 179 (40.0)
 Surgery and radiotherapy 6 (1.3)
 Surgery and chemotherapy and radiotherapy 24 (5.4)
Deads (n)
 No 199 (44.5)
 Yes 248 (55.5)
Tests
 GGT 23.1 (16.8–35.2)
 LDH 154.4 (135.7–174.2)
 TBA 4.14 (2.43–6.65)
 ALT 15.1 (11.5–20.8)
 AST 18.2 (15.8–22.1)
 ALT/AST 0.82 (0.67–1.02)